Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
Leyland-Jones, Brian
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep 2005 - 5960-72 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0732-183X
10.1200/JCO.2005.06.150 doi
Adult
Aged
Aged, 80 and over
Anemia
Breast Neoplasms--drug therapy
Epoetin Alfa
Erythropoietin--adverse effects
Female
Hematinics--adverse effects
Hemoglobins--analysis
Humans
Injections, Subcutaneous
Middle Aged
Neoplasm Metastasis
Placebos
Quality of Life
Recombinant Proteins
Survival Analysis
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep 2005 - 5960-72 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0732-183X
10.1200/JCO.2005.06.150 doi
Adult
Aged
Aged, 80 and over
Anemia
Breast Neoplasms--drug therapy
Epoetin Alfa
Erythropoietin--adverse effects
Female
Hematinics--adverse effects
Hemoglobins--analysis
Humans
Injections, Subcutaneous
Middle Aged
Neoplasm Metastasis
Placebos
Quality of Life
Recombinant Proteins
Survival Analysis